Lu AF82422 can be a mAb demonstrated as safe and perfectly tolerated inside of a stage I trial in healthful subjects and individuals with PD (NCT03611569). A period II study investigating the protection and efficacy in https://ksnr.org.in/multiple-system-atrophy/